Breakdown | ||||
Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
31.05B | 44.35B | 45.10B | 29.97B | 18.48B | Gross Profit |
1.09B | 5.84B | 9.91B | 4.70B | -1.03B | EBIT |
-1.01B | 3.57B | 7.83B | 2.54B | -3.08B | EBITDA |
2.25B | 10.60B | 14.92B | 4.19B | -5.26B | Net Income Common Stockholders |
-3.71B | 866.77M | 7.56B | -3.16B | -11.18B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
262.00M | 12.01B | 32.84B | 11.48B | 6.54B | Total Assets |
60.08B | 171.00B | 139.53B | 83.37B | 70.23B | Total Debt |
8.31B | 34.86B | 17.62B | 20.41B | 46.79B | Net Debt |
8.05B | 22.85B | -15.22B | 8.94B | 40.25B | Total Liabilities |
10.41B | 47.20B | 26.26B | 32.94B | 60.29B | Stockholders Equity |
49.67B | 53.63B | 50.41B | 30.61B | 9.94B |
Cash Flow | Free Cash Flow | |||
-24.15B | -34.46B | -21.60B | -4.41B | -10.46B | Operating Cash Flow |
4.01B | 12.20B | 6.60B | 2.26B | 85.00M | Investing Cash Flow |
-28.75B | -47.08B | -28.33B | -2.37B | -14.62B | Financing Cash Flow |
17.28B | 13.86B | 41.69B | 8.88B | 4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $3.79T | 16.62 | 8.98% | 2.46% | 6.29% | 30.68% | |
68 Neutral | ¥75.12B | 7.44 | 5.57% | 0.28% | -24.90% | ||
66 Neutral | ¥273.46B | 24.02 | -0.56% | 3.57% | 3.02% | 48.28% | |
64 Neutral | $4.39B | 11.81 | 5.17% | 249.38% | 3.98% | -12.17% | |
64 Neutral | ¥580.29B | 17.89 | 3.69% | 4.65% | 5.15% | -8.48% | |
52 Neutral | ¥14.69B | 9.97 | ― | ― | ― | ||
51 Neutral | $546.67B | 14.16 | 3.96% | 2.16% | 4.08% | -6.32% |
W-SCOPE Corporation announced an extension of the exercise period for its 3rd stock acquisition rights from April 30, 2025, to April 30, 2030. This decision, approved at the 20th Ordinary General Meeting of Shareholders, is intended to maintain motivation and prevent insider trading while avoiding stock dilution. The extension is not expected to impact the company’s business performance.
W-SCOPE Corporation’s subsidiary, W-SCOPE KOREA CO., LTD., has secured a significant order for bipolar electrodialysis (BPED) modules from POSCO Pilbara Lithium Solution, a joint venture between POSCO Holdings and Philbara Minerals Ltd. This order, valued at approximately 1 billion JPY, is part of a larger project to supply a lithium hydroxide chemical plant in South Korea, which will enhance the country’s capacity to produce lithium hydroxide for electric vehicle batteries. The deal signifies W-SCOPE’s growing influence in the lithium processing industry and is expected to contribute positively to the company’s earnings forecast, with stable demand anticipated due to increased production volumes.
W-SCOPE Corporation has announced an extension of the exercise period for its first and second series of stock acquisition rights, originally issued in 2010 and 2011. This decision aims to maintain motivation and responsibility among stakeholders while preventing insider trading and stock dilution. The extension moves the deadline to April 30, 2030, and is not expected to impact the company’s business performance.
W-SCOPE Corporation reported a 27% increase in net sales for the fiscal year ending January 31, 2025, compared to the previous year. This growth is attributed to increased shipments driven by inventory adjustments at U.S. customers, although the company still faced challenges with operating and ordinary income remaining negative.
W-SCOPE Corporation reported non-operating income and expenses for the fiscal year ending January 31, 2025, highlighting a foreign exchange gain of 1,014 million yen due to valuation gains on foreign currency-denominated receivables and payables. However, the company also faced non-operating expenses, including 367 million yen in interest expenses and 3,007 million yen in equity losses from changing WCP’s status from a consolidated subsidiary to an equity-method affiliate, impacting its financial results.
W-SCOPE Corporation announced a slight difference between its revised earnings forecast and actual results for the fiscal year ending January 2025. The company’s net sales were close to expectations, but operating and ordinary income were lower than anticipated due to a decline in the European EV market and increased inventory valuation losses. The company is implementing cost reduction strategies and seeking new contracts to mitigate these impacts.